Atlas Trials

Evaluation of 177Lu-TATE-EB-01(LNC1010)in SSTR2-positive Tumors

Clinical trial NCT05410743 · COMPLETED

Trial details

NCT number
NCT05410743
Sponsor
The First Affiliated Hospital of Xiamen University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
SSTR2-positive Tumors
Start date
2022-06-01
Primary completion
2025-03-24
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.